Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06893783RecruitingPhase 2
Tarlatamab for advanced extrapulmonary neuroendocrine carcinoma
This study tests a drug called tarlatamab for people with a rare cancer called extrapulmonary neuroendocrine carcinoma that has grown or returned after standard chemotherapy. The goal is to see if tarlatamab can help shrink tumors and improve outcomes.
SeoulAges 19 years+ - NCT06893016RecruitingPhase 3
Study of RAY1225 for adults with obesity or overweight
This trial tests a new medicine called RAY1225 to help people lose weight. If you have obesity or are overweight with related health conditions, you may be able to join.
BeijingAges 18 years+ - NCT06894303Recruiting
Remote programming for cochlear implants in routine follow-up
This study tests if cochlear implants can be adjusted remotely (without visiting the clinic) during regular follow-ups. If you have a compatible implant and sound processor, you may be able to take part from home.
ParisAges 18 years+ - NCT06894784RecruitingPhase 3
Combining two diabetes drugs with an automated insulin pump
This trial tests if adding semaglutide and empagliflozin to your automated insulin delivery system (like a smart pump) can improve blood sugar control for adults with type 1 diabetes. It may help with both glucose levels and weight management.
Montreal, QuebecAges 18 years+ - NCT06895252Recruiting
Fecal transplant and diet for new ulcerative colitis
This study tests whether a combination of fecal transplant (transferring healthy stool into your gut) and dietary changes can help control inflammation in people recently diagnosed with active ulcerative colitis. It may offer a new treatment option before starting stronger medications.
Kochi, KeralaAges 18–75 - NCT06895486RecruitingPhase 2
New oral polio vaccine study for infants
This study tests a new oral polio vaccine given to healthy infants at 16 weeks old. It aims to see if the vaccine is safe and works well to protect against polio.
Panama CityAges 1 month–2 months - NCT06896162Recruiting
Genetic test to guide first or second treatment for advanced cancer
This study looks at whether using a detailed genetic test of your tumor can help pick the best first or second treatment for advanced lung, colon, breast, or bladder cancer. The goal is to see if this personalized approach helps people live longer.
Chapel Hill, North CarolinaAges 18 years+ - NCT06896071Recruiting
A digital mental health program for teens
This trial tests a one-session digital program designed to help New Zealand teens aged 12–14 feel better mentally. It's a simple online tool you can use once during school.
CambridgeAges 12–14 - NCT06896331Recruiting
Study of brain cell activity in tumor surgery patients
This trial studies electrical signals from brain cells in people having surgery to remove a brain or cerebellum tumor. It aims to better understand how these cells work.
Pavia, PaviaAges 18 years+ - NCT06896747RecruitingPhase 1/Phase 2
Stem cell therapy for thin uterine lining
This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.
Xi'an, ShaanxiAges 20–40 - NCT06896942Recruiting
Autism doula program for Black caregivers
This study offers a doula program (a trained support person) to help Black caregivers of young children newly diagnosed with autism. It aims to see if this support improves your experience and your child's development.
Cincinnati, OhioAges 1.5 years–5.9 years - NCT06898034Recruiting
Ultrasound after childbirth to predict bleeding risk
This trial uses an ultrasound after you give birth to see if it can help predict heavy bleeding. It aims to find safer ways to monitor and prevent hemorrhage in new mothers.
Evanston, IllinoisAges 17 years+ - NCT06898255RecruitingPhase 1
GFS202A for advanced solid tumors with weight loss
This study tests a new drug called GFS202A for people with advanced solid tumors who are experiencing weight loss or have a low body mass index (cachexia). The goal is to see if the drug is safe and can help improve appetite and weight.
Guangzhou, GuangdongAges 18–80 - NCT06899360Recruiting
Age-related macular degeneration progression study
This study tracks how age-related macular degeneration (AMD) progresses over time and looks at factors that might affect your vision and quality of life. By participating, you'll help researchers understand more about AMD and what might predict better or worse outcomes.
Udine, UDAges 50–120 - NCT06900049RecruitingEarly Phase 1
Testing LE051 for boys with Duchenne muscular dystrophy (exon 51)
This study tests a new medicine called LE051 for boys with Duchenne muscular dystrophy (DMD) who have a specific genetic change that allows 'exon 51 skipping.' The goal is to see if it is safe and can help improve muscle function. Boys who join will be closely monitored for heart and lung health.
Shanghai, Shanghai MunicipalityAges 4–8 - NCT06901167Recruiting
Study of a medical in-reach program for rural nursing homes
This study looks at a new program that brings medical care into nursing homes in rural areas. It aims to see if this program helps residents get better care without needing to go to the hospital.
Ararat, VictoriaAges 65 years+ - NCT06902194Recruiting
Kids' immune response to respiratory infections study
This study looks at how South African children's immune systems respond to acute respiratory infections. It may help find better ways to treat or prevent these infections.
Cape Town, Western CapeAges Up to 13 years - NCT06902649Recruiting
Step-by-step: A new care model for kids with anger or behavior issues
This study tests a step-by-step care model for children aged 8 to 16 who struggle with anger, defiance, or aggressive behavior. The goal is to see if offering different levels of support can help families manage these behaviors effectively.
SolnaAges 8–16 - NCT06902779Recruiting
Checking if hospital and pharmacy teamwork helps after discharge
This trial tests if better communication between hospital and community pharmacists after you leave the hospital can improve your care. It focuses on patients taking many medicines and going home directly.
Rennaz, Canton of VaudAges 18 years+ - NCT06904677Recruiting
Urine test to predict colorectal cancer treatment response
This study uses a special urine test to see if it can predict how well colorectal cancer responds to treatment. If you are about to start treatment before surgery, you may be able to join by giving urine samples before and during therapy.
Beijing, Chaoyang DistrictAges 18–75 - NCT06904807RecruitingPhase 1
Safety study of LIFE-001 in healthy volunteers
This trial tests a new drug called LIFE-001 in healthy volunteers to check its safety and how the body handles it. It is for people without significant health issues.
Bayswater, VictoriaAges 18–65 - NCT06905145Recruiting
Molecular testing for advanced head and neck cancer
This trial is for people with head and neck cancer that has not spread to distant parts of the body. It is a non-treatment study that will look at the molecular features of your tumor from a biopsy sample to help guide future treatment decisions.
NaplesAges 18 years+ - NCT06905873RecruitingPhase 1
Testing FB102 for non-segmental vitiligo
This study tests a new medicine called FB102 for people with non-segmental vitiligo. It aims to see if the drug is safe and helps restore skin color.
Darlinghurst, New South WalesAges 18–75 - NCT06906042Recruiting
Imaging study of heart and liver health in volunteers
This trial uses advanced imaging (like MRI) to look at the heart and liver in people who are generally healthy. It aims to find early signs of disease and understand what normal, healthy imaging looks like.
ParisAges 20 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,382 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.